89
Participants
Start Date
February 29, 2012
Primary Completion Date
January 31, 2014
Study Completion Date
January 31, 2014
ISIS apoC-III Rx
Dose 1
ISIS apoC-III Rx
Dose 2
ISIS apoC-III Rx
Dose 3
Placebo
Dose 1
Placebo
Dose 2
Placebo
Dose 3
Farmville Internal Medicine, Farmville
Mark R. Cervi, Greenville
Physicians East, Quadrangle Medical Specialists, Greenville
Carolina East Family Medicine, Greenville
Natalie A Doyle, MD PA, Wilson
Eastern Carolina Physicians, Kinston
Isis Investigational site, Chicoutimi
Lead Sponsor
Ionis Pharmaceuticals, Inc.
INDUSTRY